In mouse models of Alzheimer’s disease [27] and HD [25], ACE inhibitors and Ang II antagonists were administrated to improve cognitive impairment by reducing mitochondrial oxidants. This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.